Eli Lilly is suing pharmacies and peptide vendors over early sales of the next big weight-loss drug: retatrutide

Eli Lilly is suing pharmacies and peptide vendors over early sales of the next big weight-loss drug: retatrutide

来源:Market Watch发布于 2026-08-12

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.

相关标的:LLY

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。